VanEck Associates’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04M Buy
130,022
+7,092
+6% +$373K ﹤0.01% 836
2026
Q1
$7.54M Sell
122,930
-34,417
-22% -$2.46M 0.01% 674
2025
Q4
$13.1M Sell
157,347
-24,354
-13% -$1.82M 0.01% 488
2025
Q3
$12.2M Buy
181,701
+40,445
+29% +$2.92M 0.01% 477
2025
Q2
$11M Sell
141,256
-10,901
-7% -$835K 0.01% 461
2025
Q1
$11.6M Sell
152,157
-22,872
-13% -$1.86M 0.02% 437
2024
Q4
$13.5M Buy
175,029
+3,349
+2% +$262K 0.02% 393
2024
Q3
$13.1M Buy
171,680
+11,677
+7% +$870K 0.02% 389
2024
Q2
$10.9M Buy
160,003
+12,658
+9% +$858K 0.02% 401
2024
Q1
$10.8M Buy
147,345
+19,690
+15% +$1.5M 0.02% 384
2023
Q4
$9.64M Buy
127,655
+8,819
+7% +$609K 0.02% 378
2023
Q3
$8.05M Buy
118,836
+32,358
+37% +$2.23M 0.02% 383
2023
Q2
$5.64M Buy
86,478
+11,408
+15% +$707K 0.01% 471
2023
Q1
$4.57M Buy
75,070
+2,643
+4% +$165K 0.01% 506
2022
Q4
$4.14M Buy
72,427
+3,909
+6% +$229K 0.01% 514
2022
Q3
$3.94M Buy
68,518
+4,353
+7% +$285K 0.01% 483
2022
Q2
$4.33M Buy
64,165
+2,347
+4% +$180K 0.01% 494
2022
Q1
$5.54M Buy
61,818
+7,447
+14% +$654K 0.01% 485
2021
Q4
$4.82M Buy
54,371
+4,925
+10% +$396K 0.01% 516
2021
Q3
$3.67M Buy
49,446
+5,172
+12% +$382K 0.01% 526
2021
Q2
$3.07M Buy
44,274
+4,354
+11% +$324K 0.01% 561
2021
Q1
$3.12M Buy
39,920
+3,831
+11% +$296K 0.01% 526
2020
Q4
$2.96M Buy
36,089
+2,751
+8% +$209K 0.01% 469
2020
Q3
$2.31M Buy
33,338
+3,835
+13% +$250K 0.01% 454
2020
Q2
$1.68M Buy
29,503
+4,551
+18% +$245K 0.01% 516
2020
Q1
$1.16M Sell
24,952
-16,576
-40% -$988K 0.01% 543
2019
Q4
$2.58M Buy
41,528
+22,642
+120% +$1.4M 0.01% 477
2019
Q3
$1.14M Buy
18,886
+1,582
+9% +$100K 0.01% 578
2019
Q2
$1.1M Buy
17,304
+8,251
+91% +$541K 0.01% 573
2019
Q1
$656K Buy
9,053
+1,015
+13% +$71K ﹤0.01% 649
2018
Q4
$510K Buy
8,038
+155
+2% +$10.8K ﹤0.01% 642
2018
Q3
$608K Sell
7,883
-105
-1% -$8.21K ﹤0.01% 659
2018
Q2
$631K Buy
+7,988
New +$628K ﹤0.01% 644
2016
Q1
Sell
-23,330
Closed -$1.4M 822
2015
Q4
$1.4M Buy
23,330
+1,500
+7% +$96.7K 0.01% 362
2015
Q3
$1.37M Buy
21,830
+2,300
+12% +$144K 0.01% 369
2015
Q2
$1.19M Sell
19,530
-5,100
-21% -$320K 0.01% 404
2015
Q1
$1.54M Buy
24,630
+21,000
+579% +$1.24M 0.01% 374
2014
Q4
$191K Hold
3,630
﹤0.01% 581
2014
Q3
$163K Hold
3,630
﹤0.01% 623
2014
Q2
$178K Buy
+3,630
New +$177K ﹤0.01% 620

Other funds holding CTSH

VanEck Associates's CTSH Position: Q2 2026 in Review

VanEck Associates increased its Cognizant (CTSH) stake by 5.8% in Q2 2026, buying an estimated $373K and bringing the position to 130,022 shares worth $5.04M. The position accounts for ﹤0.01% of the portfolio, ranked #836.

VanEck Associates first reported a position in CTSH in Q2 2014 and has held it in 40 quarters since. The position peaked at $13.5M in Q4 2024. 910 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.

  • VanEck Associates held 130,022 shares of Cognizant worth $5.04M as of Q2 2026.
  • VanEck Associates bought 7,092 Cognizant shares in Q2 2026, an estimated $373K.
  • Cognizant made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #836 holding.
  • VanEck Associates first reported a position in Cognizant in Q2 2014 and has held it in 40 quarters since.
  • VanEck Associates's Cognizant position peaked at $13.5M in Q4 2024.
  • 910 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.